Qatar to Issue COVID-19 Vaccination Certificates
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
COVID-19 and Its Implications for the Sendai Framework
Progress in Disaster Science 6 (2020) 100080 Contents lists available at ScienceDirect Progress in Disaster Science journal homepage: www.elsevier.com/locate/pdisas Invited ViewPoint Building resilience against biological hazards and pandemics: COVID-19 and its implications for the Sendai Framework ⁎ Riyanti Djalante a,b,RajibShawb,c, ,AndrewDeWitd a Academic Programme Officer, United Nations University-Institute for the Advances Study of Sustainability (UNU-IAS), Japan b Integrated Research on Disaster Risk (IRDR), Japan c Graduate School of Media and Governance, Keio University, Japan d School of Economic Policy Studies, Rikkyo University, Japan ARTICLE INFO ABSTRACT Article history: 2020 has become the year of coping with COVID-19. This year was to be the “super year” for sustainability, a year of Received 20 March 2020 strengthening global actions to accelerate the transformations required for achieving the 2030 agenda. We argue that Accepted 23 March 2020 2020 can and must be a year of both. Thus we call for more utilisation of the health-emergency disaster risk manage- Available online 24 March 2020 ment (Health-EDRM) framework to complement current responses to COVID-19 and the patent risk of similar phenom- ena in the future. To make our case, we examine current responses to COVID-19 and their implications for the SFDRR. Keywords: We argue that current mechanisms and strategies for disaster resilience, as outlined in the SFDRR, can enhance re- Sendai Framework for Disaster Risk Reduction (SFDRR) sponses to epidemics or global pandemics such as COVID-19. In this regard, we make several general and DRR- COVID-19 specific recommendations. These recommendations concern knowledge and science provision in understanding disas- Health-emergency disaster risk management ter and health-related emergency risks, the extension of disaster risk governance to manage both disaster risks and po- (Health-EDRM) tential health-emergencies, particularly for humanitarian coordination aspects; and the strengthening of community- Resilience level preparedness and response. -
COVID-19 Virtual Press Conference
COVID-19 Virtual Press conference 19 March 2021 Speaker key: CL Christian Lindmeier TAG Dr Tedros Adhanom Ghebreyesus AS Adjei Sowah TR Translator YAS Yvonne Aki-Sawyerr SO Sophie SI Simon MR Dr Michael Ryan MK Dr Maria Van Kerkhove HE Helen RG Dr Rogerio Gaspar BA Dr Bruce Aylward CO Corinne PBE Dr Peter Ben Embarek ST Stephanie NI Nina 00:00:00 CL Hello, good day wherever you're listening to us today. It's Friday, 15th March [sic] 2021. Apologies for the delay. We had some urgent last-minute changes I hope you can all accommodate. Thank you. My name is Christian Lindmeier and I'm welcoming you to today's COVID-19 press conference with a special focus on the equitable vaccine roll-out in cities. We have simultaneous interpretation available in the six official languages, Arabic, Chinese, French, English, Spanish and Russian, plus Portuguese and Hindi. Today's press conference will include three special guests representing the C40, a network of the world's megacities, to discuss equitable vaccine roll-out in cities. It's my pleasure to announce Adjei Sowah, Mayor of Accra, Ghana; Claudia Lopez, Mayor of Bogota, Colombia; Yvonne Aki- Sawyerr, Mayor of Freetown in Sierra Leone. Welcome. Now let me introduce to you the participants here in the room. We have of course Dr Tedros Adhanom Ghebreyesus, WHO Director- General, Dr Mike Ryan, Executive Director of WHO's Health Emergencies Programme, Dr Maria Van Kerkhove, Technical Lead on COVID-19, Dr Bruce Aylward, Special Advisor to the Director- General and Lead on the ACT Accelerator, and we have Dr Rogerio Gaspar, Director for Regulation and Pre-Qualification. -
Jokowi's War on Pandemic
This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Jokowi’s war on pandemic : growing dependence on TNI? Anindya, Chaula R.; Nugroho, Sigit S. 2020 Anindya, C. R., & Nugroho, S. S. (2020). Jokowi’s war on pandemic : growing dependence on TNI? (RSIS Commentaries, No. 088). RSIS Commentaries. Singapore: Nanyang Technological University. https://hdl.handle.net/10356/143646 Nanyang Technological University Downloaded on 27 Sep 2021 16:17:33 SGT Global Health Security: COVID-19 & Its Impacts Jokowi’s War on Pandemic: Growing Dependence on TNI? By Chaula R Anindya and Sigit S. Nugroho SYNOPSIS President Joko Widodo’s approach in curbing the COVID-19 outbreak has further strengthened the Indonesian Armed Forces (TNI)’s role in the country. COMMENTARY FOLLOWING THE declaration of the COVID-19 pandemic as a national disaster, President Joko Widodo (“Jokowi”) has granted the National Disaster Mitigation Agency (BNPB) a broader authority to handle the outbreak. Doni Monardo, an active three- star Army general who assumed the position of head of BNPB in 2019 before the pandemic broke out, was appointed to lead the COVID-19 Task Force. His position as head of BNPB despite being in active military service is likely to shape the country’s strategy in containing the pandemic. Relying on TNI’s organisational capabilities and networks is aimed at expediting the disaster relief effort to offset the slow response of the civilian authority to the health crisis. TNI’s Tradition in BNPB Leadership Originally, BNPB was not considered a strategic post for an active three-star general. -
HIA Company Profile
COMPANY PROFILE Hamad International Airport, a destination on its own designed for modern travellers. In a flourishing context … Hamad International Airport opened in April 2014 driven by the combined vision of His Highness Sheikh Hamad bin Khalifa Al Thani and Akbar Al Baker, Group Chief Executive of the airport. The airport opened a new era for the aviation sector in Qatar and for the Nation. One of the fastest growing economies in the world, Qatar is currently diversifying its economy away from hydrocarbons, boosting the country’s profile as a regional hub for tourism, culture, education, science and research. HIA is fully part of the equation and is actively contributing to Qatar National Vision 2030. …was born a modern and ambitious airport…. HIA is a young and sophisticated airport that was built to welcome the world’s largest aircrafts, including the A380. HIA has welcomed 35.27 million passengers and recorded 222,321 aircraft movements in 2017. Currently the airport has the capacity to handle 8,700 passengers per hour, more than 30 million passengers a year and is undergoing further expansion to accommodate more than 50 million passengers. HIA’s goal is to be one of the most operationally efficient airports in the world putting the passenger at the heart of the airport’s strategy. …situated in a strategic location… HIA is strategically located at the crossroads of East and West sides of the globe, serving more than 150 destinations across all continents. Around 80% of the world’s population is within 6-hour flight from HIA, positioning the airport as the gateway to Qatar, the Gulf and to the world. -
COVID-19 Virtual Press Conference 7 May 2021
COVID-19 Virtual Press conference 7 May 2021 Speaker key: CL Christian Lindmeier TAG Dr Tedros Adhanom Ghebreyesus MM Professor Mariana Mazzucato EM Emma MK Dr Maria Van Kerkhove MR Dr Michael Ryan DO Donato AC Dr Alejandro Cravioto AD Professor Arnaud Didierlaurent AG Agnes KOB Dr Kate O'Brien IS Isabel AN Anna CR Christiana MS Dr Mariângela Simão SO Sophie BA Dr Bruce Aylward BE Belisa JE Jeremy 00:00:30 CL Hello and good day to wherever you are listening to us today. It is Friday 7th May 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference with a focus on the new WHO Council on the Economics of Health For All. For this we have a very special guest today. I'm happy to welcome Professor Mariana Mazzucato, the Chair of the WHO Council for the Economics of Health For All and Professor in the economics of innovation and public value at University College in London and founding director of the UCL. Welcome. We have also a very special situation today because many of you have been waiting for the outcome of the tag EUL and the SAGE deliberations so we have guests for this too. We have the Chair of the TAG, Professor Arnaud Didierlaurent with us, and Professor Alejandro Cravioto, the Chair of the SAGE, for any further discussions later. But first of course here in the room we have Dr Tedros Adhanom Ghebreyesus, WHO Director-General, Dr Mike Ryan, Executive Director of WHO's Health Emergencies Programme, Dr Maria Van Kerkhove, Technical Lead on COVID- 19, Dr Soumya Swaminathan, Chief Scientist, Dr Mariângela Simão, Assistant Director-General for Access to Medicines and Health Products, and Dr Bruce Aylward, Special Advisor to the Director-General and the Lead in the ACT Accelerator. -
Adci Tf/2-Report International Civil Aviation Organization
ADCI TF/2-REPORT INTERNATIONAL CIVIL AVIATION ORGANIZATION REPORT OF THE SECOND MEETING OF THE AERODROME CERTIFICATION IMPLEMENTATION TASK FORCE ADCI TF/2 (Doha, Qatar, 12 – 14 May 2013) The views expressed in this Report should be taken as those of the MIDANPIRG Aerodrome Certification Implementation Task Force and not of the Organization. This Report will, however, be submitted to the MIDANPIRG and any formal action taken will be included in the Report of the MIDANPIRG. Approved by the Meeting and published by authority of the Secretary General The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of ICAO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontier or boundaries. TABLE OF CONTENTS PART I - HISTORY OF THE MEETING Page 1. Place and Duration .......................................................................................................... 1 2. Opening ........................................................................................................................... 1 3. Attendance ....................................................................................................................... 1 4. Officers and Secretariat ................................................................................................... 1 5. Language ........................................................................................................................ -
COVID-19 Virtual Press Conference
COVID-19 Virtual Press conference 2 October 2020 Speaker key: FC Fadela Chaib TAG Dr Tedros Adhanom Ghebreyesus MI Michelle MK Dr Maria Van Kerkhove MR Dr Michael Ryan BA Dr Bruce Aylward AN Anias KA Katrine GA Gabriela JA Jason KO Konstantin SS Dr Soumya Swaminathan LA Laurent AS Ashley EC Dr Emer Cook JO John MC Michael 00:00:49 FC Hello, everybody. I am Fadela Chaib, speaking to you from the Geneva WHO headquarters and welcoming you to our global COVID-19 press conference today, Friday, October 2nd. I'm sorry for the delay in starting this press conference. Today the briefing will focus on the COVID-19 epidemiological situation and overview. Before we go deep in developing this important aspect Dr Tedros, our Director-General, will address you first. Joining him in the room are Dr Mike Ryan, Executive Director, Emergencies Programme, Dr Maria Van Kerkhove, Technical Lead for COVID- 19, Dr Mariangela Simao, Assistant Director-General, Access to Medicines and Health Products, Dr Soumya Swaminathan, WHO Chief Scientist, and Dr Bruce Aylward, Senior Advisor to the Director-General and Lead on the ACT Accelerator. Welcome, all. This briefing is being translated simultaneously into the six official UN languages plus Portuguese and Hindi. Now without further ado I will hand over to Dr Tedros for his opening remarks. Dr Tedros, you have the floor. TAG Thank you, Fadela. Good morning, good afternoon and good evening. Overnight we heard that the President of the United States of America, Donald Trump, and First Lady, Melania Trump, tested positive for COVID-19. -
COVID-19 Special Edition #1 - March 15, 2020
3/20/2020 COVID-19 Special Edition #1 - March 15, 2020 Greetings What a difference a few weeks has made in the lives of so many people around the world....... Just a reminder for all of us to keep our front-line healthcare providers; hospital, nursing home, and other organizational staff; and our public health leaders and professionals in our thoughts and prayers as they prepare and are battling COVID-19 on behalf of patients, families, and communities across the U.S. and world. If you have a family member, friend, or neighbor that works on the front-line with patients or residents, think about how you may help them at this time - making a meal for them; taking care of their children or parents; running errands for them; etc. Each of us, as leaders in our communities, can be a valuable source of information to our patients, consumers, communities, employees, and constituents. Each week, we will provide an update on Coronavirus, also known as COVID-19 and provide links to government or health organization infographics you can readily share with others as well as written or interactive resources. COVID-19 Emergency Declaration The President declared the ongoing Coronavirus Disease 2019 (COVID-19) pandemic of sufficient severity and magnitude to warrant an emergency declaration for all states, tribes, territories, and the District of Columbia. The Emergency Declaration allows for current laws to be waived such as no charge for COVID-19 testing, treatment, and ability of providers to operate outside of some regulations to address emergency situations with COVID-19 Click Here CDC Guidance on Mass Gatherings or Large Community Events The Centers for Disease Control and Prevention (CDC) provided guidance on Sunday, March 15, recommended that for the next 8 weeks, organizers (whether groups or individual) cancel or postpone in-person events that consist of 50 people or more throughout the U.S. -
LATAM Airlines Group and Qatar Airways Sign Agreement 12.07.2016
LATAM AIRLINES GROUP AND QATAR AIRWAYS SIGN AGREEMENT Qatar Airways to acquire up to 10% of LATAM's total shares through a capital increase Farnborough, England, 12 July 2016 – LATAM Airlines Group S.A., Latin America’s leading airline group, and world-class airline Qatar Airways, both members of the oneworld alliance, announced today that they have entered into a subscription agreement providing for Qatar Airways to acquire up to 10% of LATAM’s total shares, which will be acquired in connection with a capital increase. As provided for in the subscription agreement, LATAM Airlines Group will hold an Extraordinary Shareholders Meeting no later than September 2, 2016 to propose a capital increase in the amount of US$613 million through the issuance of new shares at a price of US$10 per share. The announcement was made at the Farnborough International Air Show in England, by both airlines' CEOs: Akbar Al Baker, Group Chief Executive of Qatar Airways and Enrique Cueto, CEO of LATAM Airlines Group. "LATAM represents an exciting opportunity to invest and support the development of our long- term relationship. As a leading airline in Latin America, and key member of oneworld, this investment provides potential opportunities for Qatar Airways’ global network, alongside our successful investment in IAG," said His Excellency Mr. Akbar Al Baker, Group Chief Executive of Qatar Airways. “We are proud to announce Qatar Airways as a new shareholder of LATAM, reaffirming our bond as existing members of the oneworld alliance. This investment recognizes LATAM’s achievements and supports our project for the future. -
Virtual Press Conference 27 August 2020
COVID-19 Virtual Press conference 27 August 2020 Speaker key: MH Margaret Harris TAG Tedros Adhanom Ghebreyesus ST Stephanie MK Dr Maria Van Kerkhove MR Dr Michael Ryan JO Josephine LA Laurent NI Nina BA Dr Bruce Aylward MA Mahab SS Dr Soumya Swaminathan AD Adam TH Theo LA Latika JI Jim BI Bianca 00:00:11 MH Hello, everybody. This is Margareta Harris in WHO headquarters, Geneva welcoming you to our global press conference on COVID-19 today, this Thursday August 27th. We have with us as always in the room the WHO Director-General, Dr Tedros, along with Dr Jaouad Mahjour, our Assistant Director- General for Emergency Preparedness and the International Health Regulations, Dr Maria Van Kerkhove, Technical Lead for COVID-19, Dr Bruce Aylward, Senior Advisor to the Director- General, who leads on the ACT Accelerator, and Devora Kestel, Director of our Mental Health and Substance Use department. Dr Mariangela Simao will join us later and we're also being joined remotely by Dr Mike Ryan, Executive Director of our Emergencies Programme, and Dr Soumya Swaminathan, our Chief Scientist. As usual we are translating this simultaneously into the six official UN languages plus Portuguese and Hindi and we'll be posting the Director-General's remarks and an audio file of the press conference on the web as soon as possible. Transcripts will also be available later. Now without further delay I will hand over to Dr Tedros to give his opening remarks. Dr Tedros, you have the floor. TAG Thank you. Thank you, Margareta. Good morning, good afternoon and good evening. -
COVID-19 Long-Term Care Situation in Indonesia
The COVID-19 Long-Term Care Situation in Indonesia Tara P. Sani, Marselia Tan, Kevin Kristian Rustandi, Yuda Turana Last updated 30 May 2020 Authors Tara P. Sani (Atma Jaya Catholic University of Indonesia and Alzheimer’s Indonesia) Marselia Tan (London School of Economics and Political Sciences) Kevin Kristian Rustandi (Atma Jaya Catholic University of Indonesia) Yuda Turana (Atma Jaya Catholic University of Indonesia and Alzheimer’s Indonesia) ltccovid.org This document is available through the website ltccovid.org, which was set up in March 2020 as a rapidly shared collection of resources for community and institution-based long-term care responses to Covid-19. The website is hosted by CPEC at the London School of Economics and Political Science and draws on the resources of the International Long-Term Care Policy Network. Corrections and comments are welcome at [email protected]. This document was last updated on 30 May 2020 and may be subject to revision. Copyright: © 2020 The Author(s). This is an open-access document distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivs 3.0 Unported International License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by-nc-nd/3.0/. Suggested citation Sani TP, Tan M, Rustandi KK, Turana Y. (2020) COVID-19 Long-Term Care Situation in Indonesia. LTCcovid, International Long-Term Care Policy Network, CPEC-LSE, 30 May 2020. Acknowledgements We thank Adelina Comas-Herrera and Klara Lorenz-Dant from the CPEC/LSE for providing us with the report template and for their valuable comments. -
COVID-19 Presentation to the 16Th Meeting of the Clinical Center Research Hospital Board National Institutes of Health H
NIH Responses to COVID-19 Presentation to the 16th Meeting of the Clinical Center Research Hospital Board National Institutes of Health H. Clifford Lane, M.D. Clinical Director Deputy Director for Clinical Research and Special Projects NIAID, NIH October 16, 2020 Outline of the Presentation .Early Efforts .Organizational structure .Diagnostics .Therapeutics and Treatment Guidelines .Prevention Doctors Dodd (Biostatistician) and Davey (Principal Investigator) 2019 David Sackett Award Trial of the Year Society for Clinical Trials Scientifically robust and ethically sound clinical research remains the quickest and most efficient pathway to effective treatment and prevention strategies for patients with COVID-19. Early NIH Efforts in COVID-19 .Used the published SARS-CoV-2 sequences and obtained samples from the first US survivors to begin work on countermeasures (NIAID/VRC) .RNA vaccine (Moderna) .Monoclonal antibody (Lilly) .Initiated an RCT of the most promising antiviral at the time (Remdesivir/VekuryTM); ACTT-1 randomized controlled trial (NIAID/DMID) .Participation in the WHO Mission to China The US Journey Began January 20, 2020 . Jan. 20 – First US case diagnosed in recent traveler to Wuhan, China . Jan. 20 – Diamond Princess departed Yokohama for a 14-day cruise with stops in China, Vietnam, and Taiwan . Jan. 25 – patient who disembarked in Hong Kong diagnosed . Feb. 3 – ship quarantined in Yokohama . Among 3711 passengers and crew . 712 (19%) became infected . 331 (47%) no initial Sx . 128 (18%) never had Sx . 14 (2%) died February 16-24: NIAID's Cliff Lane Serves as Member of WHO-China Joint Mission on COVID-19 . 25 experts from China, Germany, Japan, Korea, Nigeria, Russia, Singapore, United States, and WHO .